Literature DB >> 25896767

Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABA(A) receptors.

Manoj Kumar1, Lorie A González2, Glenn H Dillon3.   

Abstract

Carisoprodol is a widely prescribed muscle relaxant, abuse of which has grown considerably in recent years. It directly activates and allosterically modulates α1β2γ2 GABAARs, although the site(s) of action are unknown. To gain insight into the actions of carisoprodol, subunit-dependent effects of this drug were assessed. Whole-cell patch clamp recordings were obtained from HEK293 cells expressing α1β2, α1β3 or αxβzγ2 (where x = 1-6 and z = 1-3) GABAARs, and in receptors incorporating the δ subunit (modeling extrasynaptic receptors). The ability to directly gate and allosterically potentiate GABA-gated currents was observed for all configurations. Presence or absence of the γ2 subunit did not affect the ability of carisoprodol to directly gate or allosterically modulate the receptor. Presence of the β1 subunit conferred highest efficacy for direct activation relative to maximum GABA currents, while presence of the β2 subunit conferred highest efficacy for allosteric modulation of the GABA response. With regard to α subunits, carisoprodol was most efficacious at enhancing the actions of GABA in receptors incorporating the α1 subunit. The ability to directly gate the receptor was generally comparable regardless of the α subunit isoform, although receptors incorporating the α3 subunit showed significantly reduced direct gating efficacy and affinity. In extrasynaptic (α1β3δ and α4β3δ) receptors, carisoprodol had greater efficacy than GABA as a direct gating agonist. In addition, carisoprodol allosterically potentiated both EC20 and saturating GABA concentrations in these receptors. In assessing voltage-dependence, we found direct gating and inhibitory effects were insensitive to membrane voltage, whereas allosteric modulatory effects were affected by membrane voltage. Our findings demonstrate direct and allosteric effects of carisoprodol at synaptic and extrasynpatic GABAARs and that subunit isoform influences these effects.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carisoprodol; Drug abuse; GABA(A) receptor; Muscle relaxant

Mesh:

Substances:

Year:  2015        PMID: 25896767      PMCID: PMC4737552          DOI: 10.1016/j.neuropharm.2015.04.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  69 in total

1.  Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.

Authors:  Jamie L Maguire; Brandon M Stell; Mahsan Rafizadeh; Istvan Mody
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

2.  Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines.

Authors:  Rebecca Dias; Wayne F A Sheppard; Rosa L Fradley; Elizabeth M Garrett; Joanna L Stanley; Spencer J Tye; Simon Goodacre; Rachael J Lincoln; Susan M Cook; Rachel Conley; David Hallett; Alexander C Humphries; Sally A Thompson; Keith A Wafford; Leslie J Street; J Luis Castro; Paul J Whiting; Thomas W Rosahl; John R Atack; Ruth M McKernan; Gerard R Dawson; David S Reynolds
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

Review 3.  Pharmacology of barbiturate tolerance/dependence: GABAA receptors and molecular aspects.

Authors:  T Ito; T Suzuki; S E Wellman; I K Ho
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

4.  Somatic dysfunction during carisoprodol cessation: evidence for a carisoprodol withdrawal syndrome.

Authors:  Roy R Reeves; Jefferson D Parker
Journal:  J Am Osteopath Assoc       Date:  2003-02

5.  Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].

Authors:  Stephanie C Licata; Donna M Platt; James M Cook; P V V Srirama Sarma; Guy Griebel; James K Rowlett
Journal:  J Pharmacol Exp Ther       Date:  2005-02-01       Impact factor: 4.030

6.  Analysis of γ-aminobutyric acid (GABA) type A receptor subtypes using isosteric and allosteric ligands.

Authors:  Richard W Olsen
Journal:  Neurochem Res       Date:  2014-07-12       Impact factor: 3.996

7.  Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys.

Authors:  Stephanie C Licata; Donna M Platt; James M Cook; Michael L Van Linn; James K Rowlett
Journal:  Psychopharmacology (Berl)       Date:  2008-11-25       Impact factor: 4.530

8.  Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol: a selective role for delta-GABA(A) receptors.

Authors:  Murray B Herd; Nicola Foister; Dev Chandra; Dianne R Peden; Gregg E Homanics; Verity J Brown; David J K Balfour; Jeremy J Lambert; Delia Belelli
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

9.  Are extrasynaptic GABAA receptors important targets for sedative/hypnotic drugs?

Authors:  Catriona M Houston; Thomas P McGee; Georgina Mackenzie; Kevin Troyano-Cuturi; Pablo Mateos Rodriguez; Elena Kutsarova; Efthymia Diamanti; Alastair M Hosie; Nicholas P Franks; Stephen G Brickley
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

Review 10.  The mechanistic classification of addictive drugs.

Authors:  Christian Lüscher; Mark A Ungless
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

View more
  4 in total

1.  Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.

Authors:  Manish Kumar; Glenn H Dillon
Journal:  Eur J Pharmacol       Date:  2016-02-09       Impact factor: 4.432

2.  Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.

Authors:  Theresa M Carbonaro; Vien Nguyen; Michael J Forster; Michael B Gatch; Laszlo Prokai
Journal:  Neuropharmacology       Date:  2020-05-29       Impact factor: 5.250

3.  The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites.

Authors:  Renqi Huang; Zhenglan Chen; Sean Dolan; John A Schetz; Glenn H Dillon
Journal:  Neuropharmacology       Date:  2017-04-27       Impact factor: 5.250

4.  A Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors.

Authors:  Manoj Kumar; Manish Kumar; John M Freund; Glenn H Dillon
Journal:  J Pharmacol Exp Ther       Date:  2017-06-22       Impact factor: 4.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.